InvestSMART

Vita Life Sciences Limited (ASX:VLS)

ALERT: Price-sensitive ASX Announcement for VLS
Current share price for VLS : $2.500 -0.1 (-3.85%)+
Announcement
Release
16 Feb 2026 3:34PM
Price at Release
$2.600
Full Release
download
Summary
Vita Life Sciences Limited reported a robust financial performance for the year ending December 31, 2025, with revenue rising by 17.3% to $93.27 million and net profit after tax increasing by 18.8% to $10.426 million. The company declared a final dividend of 9.5 cents per share, partially franked, and maintained its debt-free status, holding $35.6 million in cash reserves. Operating cash flow before interest and tax amounted to $18.4 million, contributing to a 7% increase in net assets to $56.2 million. Sales were particularly strong in Australia, Malaysia, and Singapore, and the company did not rely significantly on any single customer. The dividend reinvestment plan remains suspended.
Key Points
  • Revenue increased by 17.3% to $93.27 million.
  • Net profit after tax rose by 18.8% to $10.426 million.
  • The company declared a final dividend of 9.5 cents per share, partially franked.
  • The group's net assets were $56.2 million, reflecting a 7% increase.
  • Operating cash flow before interest and tax was $18.4 million.
  • The company remained debt-free with cash reserves of $35.6 million.
  • Sales performance was strong in Australia, Malaysia, and Singapore.
  • The dividend reinvestment plan remains suspended.
  • The company has no significant reliance on any single customer.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.